Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Report Highlights Increase in Electric Vehicle Collision Claims
Both the US and Canada see Q1 2023 rise in repairable claims frequency SAN DIEGO, Calif.—Mitchell, an Enlyte company and le
Business Insurance
In the News
Comp claims tangled by pot laws
Workers' Comp
News Release
Enlyte Named to CIO 100 Award List
Designation places company among the elite IT programs in the world CIO magazine
WorkCompWire
Article
Navigating the OnBoard Era: Streamlining Treatment Delivery in New York State
In the spring of 2022, the New York State Workers’ Compensation Board (WCB) rolled out OnBoard: Limited Release, transitioning key utilization revi
Workers' Comp
Article
Ask The Pharmacist: Exploring Drug Market Exclusivity and Generic Availability
When do drugs become generic? When drugs are first introduced, they are made available as brand name only for differing lengths of time d
Workers' Comp
Article
Medical Considerations for Referral to Field Case Management
Knowing when a claim could benefit from a referral to field case management can be complicated.